Serum markers in pre-eclampsia

References

• Armstong VW, Wieland E, Diedrich F. (1994). Serum antibodies to oxidized low-density lipoprotein in preeclampsia and coronary heart disease. Lancet 343:1570.
   PubMed Web of Science ®Google Scholar
• August P, Marcaccio B, Gertner JM, Druzin MI, Resnick LM, Laragh JH. (1992). Abnormal 1, 25-dihydroxy vitamin D metabolism in preeclampsia. Am J Obstet Gynecol 166:1295–9.
   PubMed Web of Science ®Google Scholar
• Ayhan A, Akkok E, Urman B. (1990). Beta thromboglobulin and platelet factor levels in pregnancy and preeclampsia. Gynecol Obstet Invest 30:12–14.
   PubMed Web of Science ®Google Scholar
• Ballegeer V, Spitiz B, Kiechens L. (1989). Predictive value of increased levels of fibronectin in gestational hypertension. Am J Obstet Gynecol 161:432–6.
   PubMed Web of Science ®Google Scholar
• Benyo DF, Miles TM, Conrad KP. (1997). Hypoxia stimulates cytokine production by villous explants from the human placenta. J Clin Endocrinol Metab 82:1582–8.
   PubMed Web of Science ®Google Scholar
• Branch DW, Mitchell MD, Miller E, Palinski W, Witzum JL. (1994). Preeclampsia and serum antibodies to oxidized low-density lipoprotein. Lancet 343:645–6.
   PubMed Web of Science ®Google Scholar
• Burrow RF, Hunter DJ, Andrew M. (1987). A prospective study investigating the mechanism of thrombocytopenia in preeclampsia. Obstet Gynecol 70:334–8.
   PubMed Web of Science ®Google Scholar
• Burrows RF, Kelton JG. (1990). Thrombocytopenia at delivery: a prospective survey of 6715 deliveries. Am J Obstet Gynecol 162:731–4.
   PubMed Web of Science ®Google Scholar
• Butterworth BH, Green IA, Liston WA, Haddad NG, Johnson TA. (1999). Immunocytochemical localization of neutrophil elastase in term placenta deciduas and myometrium in pregnancy- induced hypertension. Br J Obstet Gynecol 98:929–33.
   Google Scholar
• Cadroy Y, Grandjean H, Pichon J. (1993). Evaluation of six markers of hemostatic system in normal and pregnancy complicated by hypertension or preeclampsia, Br J Obstet Gynaecol 100:461–5.
   Google Scholar
• Chesley LC. (1985). Diagnosis of preeclampsia. Am J Obstet Gynecol 65:423–5.
   Google Scholar
• Chaiworapongsa T, Espinoza J, Gotsch F, Kim YM, Kim GJ, Goncalves LF. (2008). The maternal plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated in SGA and the magnitude of the increase relates to Doppler abnormalities in the maternal and fetal circulation. J Matern Fetal Med, 21:25–40.
   Google Scholar
• Cunningham FG, Lowe T, Guss S. (1985). Erythrocyte morphology in women with severe preeclampsia and eclampsia. Am J Obstet Gynecol 153:358–62.
   PubMed Web of Science ®Google Scholar
• Davidge ST, Hubel CA, Brayden RD, Capeless EC, McLaughlin MK. (1992). Sera antioxidant activity in uncomplicated and preeclamptic pregnancies. Obstet Gynecol 79:897–901.
   PubMed Web of Science ®Google Scholar
• Del Valle GO, Wolf BC, Baker CA. (2000). Free alpha-hCG: a potential marker for severe preeclampsia. J Matern Fetal Invest 3:137–40.
   Google Scholar
• Diesch CH, Holzgreve W, Hahn S, Zhong XY. (2006). Comparison of activin A and cell-free fetal DNA levels in maternal plasma from patients at high risk for preeclampsia. Prenat Diagn 26:1267–70.
   PubMed Web of Science ®Google Scholar
• Elias AN, Vaziri MD, Pandian MR. (1988). Atrial natriuretic peptide and arginine vasopressin in pregnancy and pregnancy-induced hypertension. Nephron 49:140–3.
   PubMed Web of Science ®Google Scholar
• Entman SS, Richardson LD, Moore RM. (1982). Elevated serum iron in toxemia of pregnancy. Am J Obstet Gynecol 143:398–404.
   PubMed Web of Science ®Google Scholar
• Fay RA, Bowman DR, Brooks JA. (1985). Platelets and uric acid in prediction of preeclampsia. Am J Obstet Gynecol 152:1038–9.
   PubMed Web of Science ®Google Scholar
• Hahn S, Holzgreve W. (2002). Fetal cells and cell-free fetal DNA in maternal blood:new insights into preeclampsia Hum Reprod Update 8:501–8.
   PubMed Web of Science ®Google Scholar
• Higgins JR, Papayianni A, Brady HR, Michael RN, Darling MD, Joseph JW. (1998). Circulating vascular cell adhesion molecule-1 in preeclampsia, gestational hypertension, and normal pregnancy: evidence of selective dysregulation of vascular cell adhesion molecule-1 homeostasis in preeclampsia. Am J Obstet Gynecol 179:464–9.
   PubMed Web of Science ®Google Scholar
• Hubel CA, Roberts JM, Taylor RN. (1989). Lipid peroxidation in preeclampsia: new perspectives on pre-eclampsia. Am J Obstet Gynecol 161:1025–34.
   PubMed Web of Science ®Google Scholar
• Hubel CA. (1998). Dyslipidemia, iron, and oxidative stress in preeclampsia:Assessment of maternal and feto-placental interactions. Semin Reprod Endocrinol 16:75–92.
   PubMedGoogle Scholar
• Huikeshoven FJ, Zuijderhoudt FM. (1990). Hypocalciuria in hypertensive disorder in pregnancy and how to measure it. Eur J Obstet Gynecol Reprod Biol 36:81–5.
   PubMed Web of Science ®Google Scholar
• Inglis TCM, Stuart J, George AJ. (1982). Haemostatic and rheological changes in normal pregnancy and preeclampsia. Br J Haematol 50:461–5.
   PubMed Web of Science ®Google Scholar
• Kaaja R. (1998). Insulin resistance syndrome in preeclampsia. Semin Reprod Endocrinol 16:41–6.
   PubMedGoogle Scholar
• Kharb S. (2000a). Vitamin E and C in preeclampsia. Eur J Obstet Gynecol 93:37–9.
   PubMed Web of Science ®Google Scholar
• Kharb S. (2000b). Total free radical trapping antioxidant potential in preeclampsia. Int J Gynecol Obstet 69:23–6.
   PubMed Web of Science ®Google Scholar
• Kharb S. (2000c). Lipid peroxidation in pregnancy with preeclampsia and diabetes. Gynecol Obstet Invest 50:113–16.
   PubMed Web of Science ®Google Scholar
• Kharb S, Gulati N, Singh V, Singh GP. (1998). Lipid peroxidation and vitamin E levels in preeclampsia. Gynecol Obstet Invest 46:238–40.
   PubMed Web of Science ®Google Scholar
• Kharb S, Singh GP. (2001). Hyperuricemia, oxidative stress in preeclampsia. Clin Chim Acta 305:201–3.
   PubMed Web of Science ®Google Scholar
• Kitzmiller JL, Lang JE, Yelenosky PF. (1973). Hematologic assays in preeclampsia. Am J Obstet Gynecol 11:362–7.
   Google Scholar
• Kurki T, Ailus K, Palosuo T, Ylikorkala O. (1996). Oxidized low density lipoprotein cardiolipin and phosphatidylserine fail to predict the risk of preeclampsia. Hypertens Pregn 15:251–6.
   Web of Science ®Google Scholar
• Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA. (2004). Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350:672–83.
   PubMed Web of Science ®Google Scholar
• Madazli R, Kuseyrioglu B, Uzun H, Uludag S, Ocak V. (2005). Prediction of preeclampsia with maternal mid-trimester placental growth factor, activin A, fibronectin and uterine artery Doppler velocimetry. Int J Gynaecol Obstet 89:251–7.
   PubMed Web of Science ®Google Scholar
• Molvarec A, Prohaszka Z, Nagy B, Szalay J, Fust G, Karadi I, Rigo J. (2006). Association of elevated serum heat-shock protein 70 concentration with transient hypertension of pregnancy, preeclampsia and superimposed preeclampsia: a case–control study. J Hum Hyperten 20:780–6.
   PubMed Web of Science ®Google Scholar
• Molvarec A, Prohaszka Z, Nagy B, Kalabay L, Szalay J, Fust G, Karadi I, Rigo J. (2007). Association of increased serum heat shock protein 70 and C-reactive protein concentrations and decreased serum alpha(2)-HS glycoprotein concentration with the syndrome of hemolysis, elevated liver enzymes, and low platelet count. J Reprod Immunol 73:172–9.
   PubMed Web of Science ®Google Scholar
• Molvarec A, Rigo J Jr, Lazar L, Balogh K, Mako V, Cervenak L, Mezes M, Prohaszka Z. (2009). Increased serum heat shock protein 70 levels reflect systemic inflammation, oxidative stress and hepatocellular injury in preeclampsia. Cell Stress Chaperones 14:151–9.
   PubMed Web of Science ®Google Scholar
• Powers RW, Evans RW, Majors AK. (1998). Plasma homocysteine concentration is increased in preeclampsia and is associated with evidence of endothelial activation. Am J Obstet Gynecol 179:1605–11.
   PubMed Web of Science ®Google Scholar
• Redman CW, Denson KW, Beilin LJ. (1977). Factor VIII consumption in preeclampsia, Lancet 1:1249–52.
   PubMedGoogle Scholar
• Redman CW, Boonar J, Beilin LJ. (1975). Prolactin in hypertensive pregnancies. BMJ 1:304–6.
   PubMedGoogle Scholar
• Reith A, Booth NA, Moore NR. (1993). Plasminogen activator inhibitors (PAI-1 and PAI-2) in normal pregnancies, preeclampsia and hydatiform mole. Br J Obstet Gynaecol 100:370–4.
   PubMedGoogle Scholar
• Roggensack A, Zhang Y, Davidge S. (1999). Evidence for peroxyintrite formation in the vasculature of women with preeclampsia. Hypertension 33:83–9.
   PubMed Web of Science ®Google Scholar
• Sibai BM. (1988). Pit falls in diagnosis and management of preeclampsia. Am J Obstet Gynecol 159:1–5.
   PubMed Web of Science ®Google Scholar
• Steinberg G, Khankin EV, Karumanchi SA. (2009). Angiogenic factors and preeclampsia. Thromb Res 123 (Suppl. 2):S93–9.
   Google Scholar
• Stepan H. (2009). Angiogenic factors and pre-eclampsia: an early marker is needed. Clin Sci (London) 116:231–2.
   PubMed Web of Science ®Google Scholar
• Uotila J, Solakivi T, Jaakkola O, Tuimala R, Lehtimaki T. (1998). Antibodies against copper – oxidized and malondialdehyde – modified low-density lipoproteins in preeclamptic pregnancies. Br J Obstet Gynaecol 105:1113–17.
   PubMedGoogle Scholar
• Uotila JT, Tuimala KJ, Aarnio JM. (1993). Findings on lipid peroxidation and antioxidant function in hypertensive complications of pregnancy. Br J Obstet Gynaecol 100:270–6.
   PubMedGoogle Scholar
• Varma TR. (1992). Serum uric acid levels as an index of fetal prognosis in pregnancies complicated by preexisting hypertension and preeclampsia of pregnancy. Int J Gynecol Obstet 92:401–8.
   Google Scholar
• Walsch SC. (1994). Lipid peroxidation in pregnancy. Hypertens Pregn 13:1–25.
   Web of Science ®Google Scholar
• Wataganara T, Bianchi DW. (2004). Fetal cell-free nucleic acids in the maternal circulation: new clinical applications. Ann NY Acad Sci 1022:90–9.
   PubMed Web of Science ®Google Scholar
• Weiner CP, Brandt J. (1982). Plasma antithrombin III activity: an aid in the diagnosis of preeclampsia/eclampsia. Am J Obstet Gynecol 142:275–81.
   PubMed Web of Science ®Google Scholar
• Weinstein L. (1985). Preeclampsia/eclampsia with hemolysis elevated liver enzymes, and thrombocytopenia Obstet Gynecol 66:657–70.
   PubMed Web of Science ®Google Scholar
• Weinstein L. (1982). Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol 142:159–67.
   PubMed Web of Science ®Google Scholar
• Wisdom SJ, Wilson R, McKillop JH, Walker JJ. (1991). Antioxidant system in normal pregnancy and in pregnancy – induced hypertension. Am J Obstet Gynecol 165:1701–4.
   PubMed Web of Science ®Google Scholar
• Zhong XY, Holzgreve W, Hahn S. (2002). The levels of circulatory cell free fetal DNA in maternal plasma are elevated prior to the onset of preeclampsia. Hypertens Pregn 21:77–83.
   PubMed Web of Science ®Google Scholar